Alumis (ALMS) Profit After Tax (2023 - 2025)
Alumis (ALMS) reported Profit After Tax of -$92.9 million for Q4 2025, up 1.87% year-over-year from -$91.2 million in Q4 2024, and up 16.13% quarter-over-quarter from -$110.8 million in Q3 2025.
Alumis (ALMS) Profit After Tax (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Profit After Tax data on file, last reported at -$92.9 million in Q4 2025.
- Profit After Tax for Q4 2025 came in at -$92.9 million, up 1.87% year-over-year; the trailing twelve-month figure through Dec 2025 was -$243.4 million (up 17.26% YoY), and the FY2025 annual result was -$243.3 million, up 17.29% from the prior year.
- Profit After Tax climbed to -$92.9 million in Q4 2025 per ALMS's latest filing, from -$110.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $59.3 million in Q2 2025 and troughed at -$110.8 million in Q3 2025.
- A 3-year average of -$59.7 million and a median of -$56.5 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax slumped 140.97% in 2024, then jumped 204.98% in 2025.
- A 3-year view of Profit After Tax shows it stood at -$39.3 million in 2023, then tumbled by 140.97% to -$94.7 million in 2024, then increased by 1.87% to -$92.9 million in 2025.
- Business Quant data shows ALMS's Profit After Tax at -$92.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -92.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92.93 Mn |
| Sep 30, 2025 | -110.80 Mn |
| Jun 30, 2025 | 59.32 Mn |
| Mar 31, 2025 | -98.96 Mn |
| Dec 31, 2024 | -94.70 Mn |
| Sep 30, 2024 | -93.10 Mn |
| Jun 30, 2024 | -56.51 Mn |
| Mar 31, 2024 | -49.85 Mn |
| Dec 31, 2023 | -39.30 Mn |
| Sep 30, 2023 | -43.40 Mn |
| Jun 30, 2023 | -36.29 Mn |